av/gensight-biologics--big.svg

EURONEXT:SIGHT

GenSight Biologics S.A.

  • Stock

EUR

Last Close

0.40

30/08 15:35

Market Cap

31.04M

Beta: 2.21

Volume Today

355.02K

Avg: 307.85K

PE Ratio

−0.65

PFCF: −0.75

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
700K
-
4.39M
527.71%
5.28M
20.07%
2.58M
51.06%
3M
16.19%
cost of revenue
gross profit
700K
-
4.39M
527.71%
5.28M
20.07%
2.58M
51.06%
3M
16.19%
selling and marketing expenses
34K
-
160K
370.59%
44K
72.50%
227K
415.91%
214K
5.73%
231K
7.94%
general and administrative expenses
424.65K
-
695.92K
63.88%
4.20M
503.91%
1.71M
59.34%
3.05M
78.71%
4.50M
47.38%
2.75M
38.88%
2.98M
8.36%
5.68M
90.54%
8.01M
40.95%
selling general and administrative expenses
424.65K
-
695.92K
63.88%
4.20M
503.91%
1.71M
59.34%
3.09M
80.70%
4.66M
50.94%
2.79M
40.03%
3.21M
14.78%
5.89M
83.73%
8.24M
39.75%
13.30M
61.47%
research and development expenses
2.79M
-
6.20M
122.46%
10.72M
73.02%
18.53M
72.81%
18.68M
0.79%
29.03M
55.45%
28.16M
3.01%
21.99M
21.90%
22.55M
2.57%
18.94M
16.03%
21.10M
11.42%
other expenses
-372.02K
-
-149.78K
59.74%
-1.26M
743.61%
1.78M
240.93%
2.23M
25.01%
-647K
129.07%
47K
107.26%
4.13M
8,689.36%
4.95M
19.90%
3.24M
34.54%
cost and expenses
2.84M
-
6.74M
137.57%
13.66M
102.59%
22.02M
61.18%
23.99M
8.95%
33.05M
37.75%
31.00M
6.19%
29.33M
5.39%
33.40M
13.89%
30.42M
8.93%
34.40M
13.09%
operating expenses
2.84M
-
6.74M
137.57%
13.66M
102.59%
22.02M
61.18%
23.99M
8.95%
33.05M
37.75%
31.00M
6.19%
29.33M
5.39%
33.40M
13.89%
30.42M
8.93%
34.40M
13.09%
interest expense
-75.52K
-
-72.03K
4.62%
-7.67K
89.35%
89.47K
1,266.01%
76K
15.05%
408K
436.84%
388K
4.90%
1.72M
342.53%
2.17M
26.15%
2.65M
22.35%
ebitda
-2.87M
-
-6.58M
128.98%
-13.56M
106.12%
-21.79M
60.64%
-23.81M
9.27%
-32.73M
37.46%
-29.33M
10.38%
-24.01M
18.14%
-26.83M
11.74%
-26.44M
1.44%
-31.40M
18.74%
operating income
-2.84M
-
-6.74M
137.57%
-13.66M
102.59%
-22.02M
61.18%
-23.99M
8.95%
-33.05M
37.74%
-30.30M
8.31%
-24.93M
17.70%
-28.13M
12.80%
-27.84M
1.03%
-31.40M
12.81%
depreciation and amortization
40.31K
-
255.62K
534.12%
138.65K
45.76%
202.71K
46.20%
224K
10.50%
315K
40.63%
965K
206.35%
922K
4.46%
1.30M
40.56%
1.39M
7.33%
total other income expenses net
75.52K
-
72.03K
4.62%
7.67K
89.35%
-62.98K
920.76%
-120K
90.55%
-408K
240%
-408K
0%
-9.08M
2,125.49%
-489K
94.61%
216K
144.17%
3.50M
1,520.37%
income before tax
-2.76M
-
-6.67M
141.46%
-13.65M
104.67%
-22.08M
61.73%
-24.11M
9.19%
-33.45M
38.75%
-30.71M
8.21%
-34.01M
10.77%
-28.61M
15.87%
-27.62M
3.48%
-27.90M
1.02%
income tax expense
-151.33K
-
-165.22K
9.18%
-48.98K
70.35%
62.98K
228.57%
2K
96.82%
408K
20,300%
4K
99.02%
2K
50%
2K
0%
5K
150%
-1.70M
34,100%
net income
-2.76M
-
-6.67M
141.46%
-13.65M
104.67%
-22.08M
61.73%
-24.11M
9.19%
-33.45M
38.74%
-30.71M
8.20%
-34.02M
10.77%
-28.62M
15.87%
-27.62M
3.47%
-26.20M
5.15%
weighted average shs out
13.61M
-
13.61M
0.00%
11.24M
17.41%
16.25M
44.60%
21.94M
34.97%
24.47M
11.54%
28.38M
16.00%
35.13M
23.76%
45.15M
28.54%
46.33M
2.61%
48.30M
4.25%
weighted average shs out dil
13.61M
-
13.61M
0.00%
11.24M
17.41%
16.25M
44.60%
21.94M
34.97%
24.47M
11.54%
28.38M
16.00%
35.13M
23.76%
45.15M
28.54%
46.33M
2.61%
48.30M
4.25%
eps
-0.20
-
-0.49
145.00%
-1.21
146.94%
-1.36
12.40%
-1.10
19.12%
-1.37
24.55%
-1.08
21.17%
-0.97
10.19%
-0.63
35.05%
-0.60
4.76%
-0.54
10.00%
epsdiluted
-0.20
-
-0.49
145.00%
-1.21
146.94%
-1.36
12.40%
-1.10
19.12%
-1.37
24.55%
-1.08
21.17%
-0.97
10.19%
-0.63
35.05%
-0.60
4.76%
-0.54
10.00%

All numbers in EUR (except ratios and percentages)